Cargando…

New strategies to improve clinical outcomes for diabetic kidney disease

BACKGROUND: Diabetic kidney disease (DKD), the most common cause of kidney failure and end-stage kidney disease worldwide, will develop in almost half of all people with type 2 diabetes. With the incidence of type 2 diabetes continuing to increase, early detection and management of DKD is of great c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forst, Thomas, Mathieu, Chantal, Giorgino, Francesco, Wheeler, David C., Papanas, Nikolaos, Schmieder, Roland E., Halabi, Atef, Schnell, Oliver, Streckbein, Marina, Tuttle, Katherine R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548386/ https://www.ncbi.nlm.nih.gov/pubmed/36210442 http://dx.doi.org/10.1186/s12916-022-02539-2

Ejemplares similares

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes
por: Schnell, Oliver, et al.
Publicado: (2021)

Current concepts in the management of diabetic polyneuropathy
por: Ziegler, Dan, et al.
Publicado: (2020)

Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney
por: Tuttle, Katherine R.
Publicado: (2017)

Diabetic Kidney Disease: A Call to Action: Preface
por: Tuttle, Katherine R.
Publicado: (2015)

Diabetic Neuropathy Collection: Progress in Diagnosis and Screening
por: Papanas, Nikolaos
Publicado: (2020)

Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney
por: Tuttle, Katherine R., et al.
Publicado: (2021)

Etiology, pathophysiology and classifications of the diabetic Charcot foot
por: Papanas, Nikolaos, et al.
Publicado: (2013)

Managing weight and glycaemic targets in people with type 2 diabetes—How far have we come?
por: Blüher, Matthias, et al.
Publicado: (2022)

Becaplermin gel in the treatment of diabetic neuropathic foot ulcers
por: Papanas, Nikolaos, et al.
Publicado: (2008)

Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Pafili, Kalliopi, et al.
Publicado: (2016)

Corneal confocal microscopy: Recent progress in the evaluation of diabetic neuropathy
por: Papanas, Nikolaos, et al.
Publicado: (2015)

Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?
por: Papachristou, Stella, et al.
Publicado: (2021)

Skin AGEs and diabetic neuropathy
por: Papachristou, Stella, et al.
Publicado: (2021)

COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
por: Penlioglou, Theano, et al.
Publicado: (2020)

COVID-19 and the kidney: time to take a closer look
por: Liakopoulos, Vassilios, et al.
Publicado: (2021)

The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review
por: Gouveri, Evanthia, et al.
Publicado: (2022)

Type 2 Diabetes Mellitus and Menopausal Hormone Therapy: An Update
por: Paschou, Stavroula A., et al.
Publicado: (2019)

Olfactory Dysfunction: A Complication of Diabetes or a Factor That Complicates Glucose Metabolism? A Narrative Review
por: Gouveri, Evanthia, et al.
Publicado: (2021)

Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement
por: Giorgino, Francesco, et al.
Publicado: (2018)

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
por: Schmieder, Roland E
Publicado: (2022)

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease
por: Alicic, Radica Z., et al.
Publicado: (2023)

Diabetic Peripheral Neuropathy and Depression: Dancing with Wolves? - Mini-Review and Commentary on Alghafri et al. “Screening for depressive symptoms amongst patients with diabetic peripheral neuropathy”
por: Vas, Prashanth R.J., et al.
Publicado: (2021)

Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
por: Michos, Erin D., et al.
Publicado: (2023)

Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?
por: Penlioglou, Theano, et al.
Publicado: (2021)

Evidence‐based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease
por: Tuttle, Katherine R., et al.
Publicado: (2020)

Diabetes Mellitus
por: Migdalis, Ilias, et al.
Publicado: (2014)

Complications of Diabetes
por: Papatheodorou, Konstantinos, et al.
Publicado: (2015)

APOE gene polymorphisms and diabetic peripheral neuropathy
por: Monastiriotis, Christodoulos, et al.
Publicado: (2012)

Hypertension and Diabetes: What are the pros to treating early surrogates?
por: Schmieder, Roland E.
Publicado: (2009)

Complications of Diabetes 2016
por: Papatheodorou, Konstantinos, et al.
Publicado: (2016)

Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece
por: Migdalis, Ilias N., et al.
Publicado: (2021)

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
por: de Boer, Ian H., et al.
Publicado: (2022)

Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece
por: Migdalis, Ilias N., et al.
Publicado: (2022)

Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors
por: Tuttle, Katherine R.
Publicado: (2023)

Erratum. Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes 2019;68:248–257
por: Alicic, Radica Z., et al.
Publicado: (2019)

Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials
por: Tuttle, Katherine R., et al.
Publicado: (2022)

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
por: Schnell, Oliver, et al.
Publicado: (2023)

Hyperbaric Oxygen Therapy in Ischaemic Foot Ulcers in Type 2 Diabetes: A Clinical Trial
por: Perren, Sarah, et al.
Publicado: (2018)

Diabetes Mellitus 2014
por: Migdalis, Ilias, et al.
Publicado: (2015)

Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial
por: Polonsky, William H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_78mbng4fgbnnd1dge4ofemkn8j